MH+

(redirected from Malignant Hyperthermia Susceptible)
AcronymDefinition
MH+Malignant Hyperthermia Susceptible (muscles)
References in periodicals archive ?
Safe duration of post-operative monitoring for malignant hyperthermia susceptible patients.
Olthoff, "Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation," Clinical Genetics, vol.
Preparation of the Drager Fabius anesthesia machine for the malignant hyperthermia susceptible patient.
Localization of the gene encoding the [alpha]2/[delta]-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.
Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families.
Individuals who are malignant hyperthermia susceptible (MHS) have been identified in Europe (the European Malignant Hyperthermia group) and North America (the North American Malignant Hyperthermia group) using an in vitro contracture test (2,7).
Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
DNA from 34 malignant hyperthermia susceptible individuals and four malignant hyperthermia equivocal subjects was examined using direct sequencing of 'hot-pots' in the RYR1 gene to identify mutations associated with malignant hyperthermia.
Localization of the gene encoding the alpha-2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.
Enhanced response to caffeine and 4-CmC in malignant hyperthermia susceptible muscle is related in part to chronically elevated resting [[Ca.sup.2+]]i.
Patients who are malignant hyperthermia susceptible are often admitted overnight for observation, even after minor surgery.
This audit suggests that malignant hyperthermia susceptible patients can be safely managed as day stay patients in appropriate facilities, with appropriate postoperative care.
Full browser ?